{"name":"PregLem SA","slug":"preglem-sa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"PGL4001","genericName":"PGL4001","slug":"pgl4001","indication":"Heavy menstrual bleeding","status":"phase_3"},{"name":"PGL4001 matching placebo and iron","genericName":"PGL4001 matching placebo and iron","slug":"pgl4001-matching-placebo-and-iron","indication":"Prevention of recurrent miscarriage in women with progesterone deficiency","status":"phase_3"},{"name":"PGL4001, placebo, drug free period","genericName":"PGL4001, placebo, drug free period","slug":"pgl4001-placebo-drug-free-period","indication":"Prevention of preterm birth in women at risk for spontaneous preterm labor","status":"phase_3"},{"name":"PGL4001, progestin","genericName":"PGL4001, progestin","slug":"pgl4001-progestin","indication":"Heavy menstrual bleeding","status":"phase_3"},{"name":"PGL4001, progestin, drug free period","genericName":"PGL4001, progestin, drug free period","slug":"pgl4001-progestin-drug-free-period","indication":"Hormonal contraception with scheduled menstrual cycling","status":"phase_3"},{"name":"Ulipristal Acetate - open label","genericName":"Ulipristal Acetate - open label","slug":"ulipristal-acetate-open-label","indication":"Emergency contraception","status":"phase_3"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"PGL4001 (ulipristal) and iron","genericName":"PGL4001 (ulipristal) and iron","slug":"pgl4001-ulipristal-and-iron","indication":"Uterine fibroids (leiomyomas) with heavy menstrual bleeding","status":"phase_3"}]}],"pipeline":[{"name":"PGL4001","genericName":"PGL4001","slug":"pgl4001","phase":"phase_3","mechanism":"PGL4001 is a selective progesterone receptor modulator that acts as a progesterone agonist to reduce uterine contractions and bleeding.","indications":["Heavy menstrual bleeding","Uterine fibroids (leiomyomas)"],"catalyst":""},{"name":"PGL4001 (ulipristal) and iron","genericName":"PGL4001 (ulipristal) and iron","slug":"pgl4001-ulipristal-and-iron","phase":"phase_3","mechanism":"Ulipristal is a selective progesterone receptor modulator that suppresses ovulation and alters the endometrium, while iron supplementation addresses iron deficiency anemia.","indications":["Uterine fibroids (leiomyomas) with heavy menstrual bleeding","Iron deficiency anemia secondary to heavy menstrual bleeding"],"catalyst":""},{"name":"PGL4001 matching placebo and iron","genericName":"PGL4001 matching placebo and iron","slug":"pgl4001-matching-placebo-and-iron","phase":"phase_3","mechanism":"PGL4001 is a selective progesterone receptor agonist that promotes endometrial decidualization and suppresses uterine contractions to prevent miscarriage.","indications":["Prevention of recurrent miscarriage in women with progesterone deficiency","Treatment of threatened abortion"],"catalyst":""},{"name":"PGL4001, placebo, drug free period","genericName":"PGL4001, placebo, drug free period","slug":"pgl4001-placebo-drug-free-period","phase":"phase_3","mechanism":"PGL4001 is a selective progesterone receptor agonist that promotes uterine quiescence and prevents preterm labor.","indications":["Prevention of preterm birth in women at risk for spontaneous preterm labor"],"catalyst":""},{"name":"PGL4001, progestin","genericName":"PGL4001, progestin","slug":"pgl4001-progestin","phase":"phase_3","mechanism":"PGL4001 is a selective progesterone receptor agonist that mimics the action of the natural hormone progesterone to modulate uterine contractility and endometrial function.","indications":["Heavy menstrual bleeding","Preterm labor prevention"],"catalyst":""},{"name":"PGL4001, progestin, drug free period","genericName":"PGL4001, progestin, drug free period","slug":"pgl4001-progestin-drug-free-period","phase":"phase_3","mechanism":"PGL4001 is a selective progesterone receptor modulator that provides contraceptive and menstrual regulation effects through progestin activity with a structured drug-free period.","indications":["Hormonal contraception with scheduled menstrual cycling"],"catalyst":""},{"name":"Ulipristal Acetate - open label","genericName":"Ulipristal Acetate - open label","slug":"ulipristal-acetate-open-label","phase":"phase_3","mechanism":"Ulipristal acetate is a selective progesterone receptor modulator that acts as an antagonist to progesterone.","indications":["Emergency contraception","Treatment of moderate to severe symptoms of uterine fibroids"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":7,"phaseCounts":{"phase_3":7},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}